ArcticZymes Technologies ASA (OSL:AZT)

kr 16.8 -0.2 (-1.18%) Market Cap: 858.00 Mil Enterprise Value: 626.50 Mil PE Ratio: 57.54 PB Ratio: 2.58 GF Score: 76/100

Q2 2024 Arcticzymes Technologies ASA Earnings Call Transcript
Aug 22, 2024

kr21.8 (+3.81%)

Earnings
Q1 2024 Arcticzymes Technologies ASA Earnings Call Transcript
May 08, 2024

kr23.75 (-5.94%)

Earnings
Q4 2023 Arcticzymes Technologies ASA Earnings Call Transcript
Feb 01, 2024

kr33.85 (-16.11%)

Earnings
Q3 2023 Arcticzymes Technologies ASA Earnings Call Transcript
Nov 02, 2023

kr32.45 (+17.36%)

Earnings
Q2 2023 Arcticzymes Technologies ASA Earnings Call Transcript
Aug 17, 2023

kr34.9 (+1.60%)

Earnings
Q1 2023 Arcticzymes Technologies ASA Earnings Call Transcript
May 04, 2023

kr37.5 (-4.58%)

Earnings
Q4 2022 Arcticzymes Technologies ASA Earnings Call Transcript
Feb 02, 2023

kr42.78 (-4.17%)

Earnings
Q3 2022 Arcticzymes Technologies ASA Earnings Call Transcript
Oct 27, 2022

kr66.25 (-10.17%)

Earnings
Q2 2022 Arcticzymes Technologies ASA Earnings Call Transcript
Aug 18, 2022

kr77.55 (-6.45%)

Earnings
Q1 2022 Arcticzymes Technologies ASA Earnings Presentation Transcript
Apr 28, 2022
Q4 2021 Arcticzymes Technologies ASA Earnings Call Transcript
Jan 27, 2022

kr91.8 (+12.09%)

Earnings
Q3 2021 Arcticzymes Technologies ASA Earnings Call Transcript
Oct 28, 2021

kr91.5 (+12.48%)

Earnings
Q2 2021 Arcticzymes Technologies ASA Earnings Call Transcript
Aug 19, 2021

kr78.8 (-19.96%)

Earnings
Q1 2021 Arcticzymes Technologies ASA Earnings Call Transcript
Apr 22, 2021

kr83.75 (+21.38%)

Earnings
Q4 2020 Arcticzymes Technologies ASA Earnings Call Transcript
Jan 28, 2021

kr62.6 (-12.32%)

Earnings
ArcticZymes Technologies ASA - Special Call Transcript
Dec 15, 2020
Q3 2020 Arcticzymes Technologies ASA Earnings Call Transcript
Oct 22, 2020

kr65 (-20.73%)

Earnings
Q2 2020 Arcticzymes Technologies ASA Earnings Call Transcript
Aug 19, 2020

kr57 (+17.28%)

Earnings
Q1 2020 Biotec Pharmacon ASA Earnings Call Transcript
Apr 23, 2020

kr12.75 (+52.15%)

Earnings
Q4 2019 Biotec Pharmacon ASA Earnings Call Transcript
Jan 30, 2020

kr7.8 (+21.88%)

Earnings
Biotec Pharmacon ASA - Special Call Transcript
Dec 10, 2019
Q2 2019 Biotec Pharmacon ASA Earnings Call Transcript
Aug 15, 2019

kr3.7

Earnings
Q1 2019 Biotec Pharmacon ASA Earnings Call Transcript
Apr 30, 2019

kr4.27 (+0.23%)

Earnings

Biotec Pharmacon ASA - Special Call Transcript

Dec 10, 2019 / 01:00PM GMT

Release Date Price: kr4.76 (-0.83%)

Transcript

Marie Ann Roskrow

Biotec Pharmacon ASA - Chairperson

So good afternoon, ladies and gentlemen, and welcome to the Investor Update Meeting. We've basically set aside 1.5 hours for the meeting. So Jethro, who I'll introduce in a moment, will give a presentation -- and those are the slides I just handed out -- of roughly about 0.5 hour, and then that will leave us an hour, give or take, to answer your questions.

We do have to leave promptly on time because we're dashing to another meeting. So I hope you appreciate that. And I think that's plenty of time that we can have a good question-and-answer session as well.

What we'd like to focus on today? Please come in gentlemen. What we'd like to focus on in the presentation is the current situation, obviously, is what's going on at Biotec Pharmacon and I think in more detail to lay out what our plans are for the future and where we see the excitement and the growth within this company.

This year, as many of you know, because you're seasoned shareholders in this company, we've had to take some strategic and difficult decisions. And I

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.